Page last updated: 2024-10-21

vanilmandelic acid and Carcinoma, Medullary

vanilmandelic acid has been researched along with Carcinoma, Medullary in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinlaw, WB1
Scott, SM1
Maue, RA1
Memoli, VA1
Harris, RD1
Daniels, GH1
Porter, DM1
Belloni, DR1
Spooner, ET1
Ernesti, MM1
Noll, WW1

Other Studies

1 other study available for vanilmandelic acid and Carcinoma, Medullary

ArticleYear
Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Clinical endocrinology, 2005, Volume: 63, Issue:6

    Topics: Adolescent; Adult; Calcitonin; Calcium; Carcinoma, Medullary; Catecholamines; Child; Codon; Female;

2005